(Q41394915)

30 September 2017

Changes in intensive care for allogeneic hematopoietic stem cell transplant recipients (English)

1 reference

30 September 2017

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25798675%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Frédéric Pène

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25798675%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

author name string

E Lengliné

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25798675%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

A-S Moreau

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25798675%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

F Blot

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25798675%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

J-H Bourhis

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25798675%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

A Buzyn

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25798675%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

B Schlemmer

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25798675%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

G Socié

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25798675%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

E Azoulay

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25798675%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

language of work or name

English

0 references

publication date

23 March 2015

1 reference

Bone Marrow Transplantation

30 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25798675%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

volume

50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25798675%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

page(s)

840-845

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25798675%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25798675%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/bmt.2015.55

7 June 2020

exact match

0 references

cites work

Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: a Global Observational Study.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.55

In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.55

Hematopoietic cell transplantation in patients with myelodysplastic syndrome or acute myeloid leukemia arising from myelodysplastic syndrome: similar outcomes in patients with de novo disease and disease following prior therapy or antecedent hematol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.55

How I treat acquired aplastic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.55

Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.55

Acute graft-versus-host disease: from the bench to the bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.55

Critical care of the hematopoietic stem cell transplant recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.55

Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.55

Outcome and prognostic factors of hematopoietic stem cell transplantation recipients admitted to a medical ICU.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.55

Reduced mortality after allogeneic hematopoietic-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.55

Hematopoietic cell transplantation-specific comorbidity index predicts inpatient mortality and survival in patients who received allogeneic transplantation admitted to the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.55

Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium--a groupe de recherche respiratoire en réanimation onco-hématologique study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.55

Intensive care unit management of patients with newly diagnosed acute myeloid leukemia with no organ failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.55

Intensive care of the cancer patient: recent achievements and remaining challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.55

Defining the intensity of conditioning regimens: working definitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.55

Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.55

Survival in neutropenic patients with severe sepsis or septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.55

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.55

The ICU trial: a new admission policy for cancer patients requiring mechanical ventilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.55

Hematopoietic SCT in Europe: data and trends in 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.55

Peripheral-blood stem cells versus bone marrow from unrelated donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.55

Outcome of recipients of bone marrow transplants who require intensive-care unit support

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.55

Risk factors for ICU admission and ICU survival after allogeneic hematopoietic SCT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.55

Outcome in critically ill patients with allogeneic BM or peripheral haematopoietic SCT: a single-centre experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.55

Intensive care outcomes in bone marrow transplant recipients: a population-based cohort analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.55

Patterns of cytomegalovirus reactivation are associated with distinct evolutive profiles of immune reconstitution after allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.55

Cytomegalovirus reactivation and associated outcome of critically ill patients with severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.55

Outcomes of mechanically ventilated hematology patients with invasive pulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.55

Predictors of noninvasive ventilation failure in patients with hematologic malignancy and acute respiratory failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.55

Kidney complications of hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.55

Acute kidney injury in critically ill allo-HSCT recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.55

Impact of case volume on survival of septic shock in patients with malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.55

High-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease and implication for its molecular mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.55

Diagnostic Strategy for Hematology and Oncology Patients with Acute Respiratory Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.55

Sequential Organ Failure Assessment predicts the outcome of SCT recipients admitted to intensive care unit

21 January 2018

1 reference

12 December 2020

Intensive care unit support and Acute Physiology and Chronic Health Evaluation III performance in hematopoietic stem cell transplant recipients

1 reference

12 December 2020

2010 report from the Center for International Blood and Marrow Transplant Research (CIBMTR): current uses and outcomes of hematopoietic cell transplants for blood and bone marrow disorders

1 reference

12 December 2020

Prognostic indicators for blood and marrow transplant patients admitted to an intensive care unit

1 reference

12 December 2020

Multicenter outcome study of cancer patients admitted to the intensive care unit: a probability of mortality model

1 reference

12 December 2020

Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma.

1 reference

12 December 2020

IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade

1 reference

12 December 2020

Cytomegalovirus reactivation in critically ill immunocompetent patients

1 reference

12 December 2020